Pharmacokinetics and Therapeutic Drug Monitoring of Newer Antiepileptic Drugs
- Author:
Dae Won SEO
1
Author Information
1. Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. daewon@skku.edu
- Publication Type:Review
- Keywords:
Epilepsy;
Antiepileptic drug;
Therapeutic drug monitoring;
Pharmacokinetics
- MeSH:
Anticonvulsants;
Drug Interactions;
Drug Monitoring;
Epilepsy;
Humans
- From:Journal of Korean Epilepsy Society
2011;15(1):1-9
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Recently a newer generation of antiepileptic drugs has been developed and rational polytherapy has become popular in everyday clinical practice for epilepsy management. All of newer antiepileptic drugs (AED) have undergone extensive clinical studies, but the information on the relationship between concentrations and effects is scarce. The concentration can depend on the individual variation, but explain the efficacy and toxicity in individual patient management. We assess the potential value of measuring the level of newer AED, which is one of therapeutic drug monitoring (TDM). The value of TDM is discussed based on pharmacokinetic characteristics and drug interactions. Although routine TDM in general cannot be recommended, TDM of the newer AED may be of value in selected cases.
